BioTech News at Arizona Biotech
Biotech News <<< Mailing List
Biotechnology News <<< Discussion Forums
Saturday, September 03, 2005
Bay Area biotech firms release terms of IPOs ITCA SNSS
Inside Bay Area - Business News
Bay Area biotech firms release terms of IPOs
Two Bay Area biotechnology firms announced terms for initial public offerings of stock.
Emeryville-based Intarcia Therapeutics Inc., which is developing breast cancer and hepatitis C treatments, Friday announced the terms for an IPO worth as much as $70 million.
The stock is expected to list on the Nasdaq Stock Market under the symbol "ITCA."
Underwriters for Sunesis Pharmaceuticals Inc. on Thursday set the terms of the company's pending IPO at 6 million shares with an estimated price range of between $9 and $11 a share.
Sunesis company said it plans to list its common stock on the Nasdaq National Market under the symbol "SNSS."
Arizona Biotech
Biotech News
Arizona Entrepreneurs
Arizona High Tech

